Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Long-Term Deferred Tax (2023 - 2024)

Onconetix (ONCO) has disclosed Long-Term Deferred Tax for 1 consecutive years, with $1.3 million as the latest value for Q4 2023.

  • On a quarterly basis, Long-Term Deferred Tax changed N/A to $1.3 million in Q4 2023 year-over-year; TTM through Dec 2023 was $1.3 million, a N/A change, with the full-year FY2023 number at $1.3 million, changed N/A from a year prior.
  • Long-Term Deferred Tax was $1.3 million for Q4 2023 at Onconetix.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $1.3 million in Q4 2023 to a low of $1.3 million in Q4 2023.